Joshua Duggan, PA
Physician Assistant · Dover, NHNPI 1528205564
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,352 of the $11,510 with a category attached, or 81.3%. 32 manufacturers reported payments, led by Boston Scientific at 42.2% of the total. Reporting peaked in 2021 at $3,828 and has fallen 52.0% since, to $1,838 in 2025. Among physician assistant clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 412 payments — averaging $27.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Teva Pharmaceuticals USA, Inc.$411
- Collegium Pharmaceutical, Inc.$391
- Johnson & Johnson$334
- plus $2K from 26 others
What the payments were for
- Travel & lodging$2,15819%
- Food & beverage$9,35281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 85 | $4,863 |
| AbbVie(2 entities) | 91 | $2,129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 74 | $1,186 |
| Teva Pharmaceuticals USA, Inc. | 20 | $411 |
| Collegium Pharmaceutical, Inc. | 28 | $391 |
| Johnson & Johnson | 11 | $334 |
| Pfizer | 13 | $292 |
| IBSA Pharma Inc. | 7 | $223 |
| Painteq LLC | 5 | $161 |
| Amgen | 7 | $157 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $135 |
| Lundbeck LLC | 5 | $110 |
| Valinor Pharma, LLC | 5 | $108 |
| Biodelivery Sciences International, Inc. | 6 | $103 |
| Ultragenyx Pharmaceutical Inc. | 4 | $95 |
| GRT US Holding, Inc. | 6 | $92 |
| Lilly USA, LLC | 5 | $86 |
| Redhill Biopharma Inc. | 4 | $76 |
| Almatica Pharma LLC | 3 | $76 |
| Vertex | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 4 | $61 |
| Si-bone, Inc. | 1 | $56 |
| Merz Pharmaceuticals, LLC | 2 | $53 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Averitas Pharma Inc. | 2 | $38 |
| AstraZeneca | 1 | $32 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Spinal Simplicity, LLC | 1 | $27 |
| Relievant Medsystems, Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Indivior Inc. | 1 | $16 |
| Nevro Corp. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$1,840
- WAVEWRITER ALPHA$1,209
- GENERAL - THERAPIES$148
How this compares
$11,510 in reported general payments places this provider in the 95th percentile of 782 physician assistant providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 55 | $32,621 |
| Nurtec OdtRimegepant Sulfate | 16 | $31,226 |
| UbrelvyUbrogepant | 20 | $28,825 |
| Buprenorphine | 56 | $12,967 |
| Oxycodone Hcl | 378 | $6,591 |
| OxycontinOxycodone Hcl | 26 | $6,059 |
| Gabapentin | 294 | $5,996 |
| Tizanidine Hcl | 333 | $5,755 |
| Naloxone Hcl | 79 | $4,382 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 182 | $3,752 |
| Morphine Sulfate ErMorphine Sulfate | 101 | $3,690 |
| Pregabalin | 193 | $3,329 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $3,290 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 92 | $2,269 |
| Buprenorphine Hcl | 40 | $2,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $391 | $32,62155 claims |
| PfizerNurtec Odt | $292 | $31,22616 claims |
| AbbVieUbrelvy | $2,129 | $28,82520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 782 physician assistant providers in New Hampshire.
Other physician assistant in Dover
- Shelley LandryDover$5K
- Alaina IannazziDover$4K
- Michelle RyderDover$2K
- Leah CloughDover$2K
- Joseph ZucchiSalem$40K
- Lindsay OverkoConcord$29K
- Evelyn SteinPortsmouth$26K
- Shari AshtonManchester$24K
- Jacqueline WattsStratham$22K
- Ryan StrasserStratham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.